KESIMPTA
LIVE

Serial Number

79227649

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jan 15, 2018

Add to watchlist:

No watchlists yet
View on USPTO

KESIMPTA Trademark

Serial Number: 79227649 • Registration: 5537963

KESIMPTA is a trademark filed by NOVARTIS AG on January 15, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 15, 2018

Registration Date

August 14, 2018

Published for Opposition

May 29, 2018

Goods & Services

[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; ] pharmaceutical preparations acting on the central nervous system [ ; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Dec 25, 2025 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 7, 2025 INPS
INVALIDATION PROCESSED
Nov 7, 2025 INPC
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Oct 18, 2025 NA15
REGISTERED - SEC. 15 ACKNOWLEDGED
Oct 18, 2025 15AK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 18, 2025 APRE
TEAS SECTION 15 RECEIVED
Oct 6, 2025 E15R
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 9, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Oct 9, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Oct 9, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 7, 2024 APRE
TEAS SECTION 71 RECEIVED
Feb 9, 2024 ES71
NOTIFICATION PROCESSED BY IB
Oct 12, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 21, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 21, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Sep 13, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Aug 14, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Jun 2, 2018 GPNX
PUBLISHED FOR OPPOSITION
May 29, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 16, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 16, 2018 OP2R
NOTICE OF PUBLICATION
May 9, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 26, 2018 CNSA
ASSIGNED TO EXAMINER
Apr 25, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 13, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 7, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 1, 2018 REPR